View in EDS

Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer.

Saved in:
Bibliographic Details
Title: Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer.
Authors: Rödel F; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Fleischmann M; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Diefenhardt M; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Dapper H; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany., Hoffmann A; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany., Rödel C; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Martin D; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Fokas E; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany. emmanouil.fokas@uk-koeln.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany. emmanouil.fokas@uk-koeln.de.; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany. emmanouil.fokas@uk-koeln.de.
Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2025 Jul; Vol. 22 (7), pp. 483-498. Date of Electronic Publication: 2025 May 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1759-4782
DOI:10.1038/s41571-025-01025-x